Cargando…
Abstract 149: Hyperphosphatemic familial tumoral calcinosis due to homozygous mutation at Leu366Arg: First case report
Background: Hyperphosphatemic familial tumoral calcinosis (HFTC) is a rare disabling autosomal recessive metabolic disorder characterized by hyperphosphatemia and manifestations ranging from progressive deposition of calcium phosphate crystals in the skin, soft tissues and bone, and hyperostosis. Th...
Autores principales: | Shukla, Ajay, Gupta, Sushil Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067761/ http://dx.doi.org/10.4103/2230-8210.342274 |
Ejemplares similares
-
Abstract 127: Pituitary resistance to thyroid hormone due to a novel mutation in the NCOR2 gene: The first case report
por: Shukla, Ajay, et al.
Publicado: (2022) -
Abstract 69: A novel variant of MTHFR homozygous mutation causing hyperhomocystinemia in a case presenting as tall stature
por: Pande, Arunkumar R, et al.
Publicado: (2022) -
Abstract 112: Post-COVID vaccination ASIA syndrome (autoimmune/inflammatory syndrome induced by adjuvants) and thyroid dysfunction
por: Singhal, Vaibhav, et al.
Publicado: (2022) -
Familial Hyperphosphatemic Tumoral Calcinosis
por: Saifuddin, Mohammad, et al.
Publicado: (2023) -
Abstract 158: Comparison of different screening tools for predicting osteoporosis in community dwelling post-menopausal women
por: Singhal, Vaibhav, et al.
Publicado: (2022)